Clinical Trials Browser

Phase 2 × Small Cell Lung Carcinoma × prexasertib × Clear all

NCT02735980 2020-03-17

A Study of Prexasertib (LY2606368) in Participants With Extensive Stage Disease Small Cell Lung Cancer

Phase 2 Completed

133 enrolled 20 charts

Small Cell Lung Carcinoma